An effective development program hinges on the generation of a robust and dependable cell line.

Recognizing the importance of this activity, and how a good starting point will optimize your success, 3P Biopharmaceuticals offers to manage your cell line development. Our expertise covers the entire process, from ensuring the amino acid or nucleotide sequence to generating a stable Research Cell Bank (RCB) that will be thoroughly characterized to give confidence for superior performance.

As this activity is also key for CMC documentation, 3P ensures full traceability of all operations performed, as well as a complete history of the cell line, vector and plasmid used to construct the final RCB.

3P biopharmaceuticals also has capabilities to generate your Master Cell Bank (MCB) and/or Working Cell Bank (WCB) to deliver reproducible quality and safety during commercial production.

Biopharmaceuticals are the future

The manufacture of mammalian biopharmaceuticals has become a major global enterprise. We are committed to working with you to drive your mammalian manufacturing to success.

3P’s manufacturing facilities provide single-use technology for cost-effective production, reducing the possibility of cross contamination and enabling faster manufacturing.

As part of our one-stop-shop service, we also offer a wide variety of in-house analytical testing and release capabilities to support the quality manufacturing of your clinical or commercial-stage products.

Cell line experience:

• CHO
• NS0
• BHK
• HEK
• Hybridomas
• Other cell types

Single-use bioreactor capacities: